Label claim: what the number on a peptide vial means
The amount a product's label says it contains, such as the milligrams of peptide per vial. Assay results are often reported as a percentage of label claim, which only makes sense if it is clear whether the label means peptide or powder.
Short answer
The label claim is the amount of active substance a product says it contains, such as 10 mg per vial. Laboratories use it as the reference for an amount result and report the measured milligrams as a percentage of the claim. A claim is a statement by whoever printed the label, not a measurement.
What exactly is a label claim?
A label claim is the quantity a product's label says is present. For a peptide vial it is usually a single figure in milligrams per vial. In quality testing it has a specific job: it is the target a measured amount is judged against. An amount result reads as so many milligrams found, and so many percent of label claim.
The claim belongs to whoever printed the label. It is not evidence on its own. A certificate that repeats the label figure without measuring anything has checked nothing about amount.
Three vials with a dashed label line: one measuring under the line, one on it, one over it, labelled underfilled, on label and overfilled.
How is a result reported against the label claim?
A laboratory measures the milligrams of peptide in the vial with an assay against a reference standard, then compares the result with the claim. You will see it written in one of three ways.
| Format | What it shows |
|---|---|
| Measured mg | The milligrams of peptide found in the vial |
| Percent of label claim | Measured milligrams divided by the label figure, times 100 |
| Difference from label | How far above or below the label the measurement sits, as a percentage |
All three describe the same measurement. The lesson on amount versus label explains how a laboratory gets from a peak on a chromatogram to milligrams, and the guide to underdosed vials covers how the difference is scored.
Can a vial be over its label claim?
Yes, and it is reported the same way. Published work shows how far claims can drift in an unregulated market. In a 2024 study of freeze dried semaglutide bought from online sellers without a prescription, the measured semaglutide content exceeded the labelled amount by between 28.56% and 38.69% (Ashraf et al., J Med Internet Res, 2024). An amount well above the claim is not a bonus. It means the label does not describe the vial. See overfill and underfill.
Does the claim refer to the salt or the peptide?
Labels rarely say. A claim of 10 mg can mean 10 mg of powder as weighed, which includes counter-ions and water, or 10 mg of the peptide itself. For approved medicines the US FDA applies the USP Salt Policy, under which strength is expressed in terms of the active moiety, using the example "100 mg newdrug" rather than "123.7 mg newdrug hydrochloride" (FDA guidance on salt drug substances). That example is the FDA's own illustration, not a peptide, and research peptide labels follow no such rule.
This matters when you read an amount result. If the label means powder and the laboratory measures peptide, a carefully filled vial can still read below its claim. The gap is explained by net peptide content, not by underfilling. A good report states which basis its measurement uses.
What should a label claim include?
- The compound name, matching the name on any certificate offered for it.
- The amount with its unit, per vial.
- A batch or lot code, so a certificate can be matched to the vial in your hand.
- Ideally the salt form, such as acetate, so the basis of the figure is clear.
A label without a batch code cannot be tied to any certificate, however good that certificate looks.
What can a label claim not tell you?
Identity needs mass spectrometry, purity needs HPLC and amount needs an assay. Each is its own line on a certificate, and the label claim is only the yardstick for the last one.
Related terms: Assay, Overfill, Underfill, Gross weight
Sources
- Ashraf AR et al. Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription. J Med Internet Res. 2024;26:e65440, Journal of Medical Internet Research (PMC)
- Naming of Drug Products Containing Salt Drug Substances, Guidance for Industry, US Food and Drug Administration
- McCarthy D et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharm Res. 2023;40(6):1317-1328, Pharmaceutical Research (PMC)